Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (yeni pencere açar)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Kaynak‎: Int J Gynaecol Obstet 2016;134(3):324-8.

İndeks‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (yeni pencere açar)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (yeni pencere açar)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Kaynak‎: Cochrane Database Syst Rev 2018;4:CD011689.

İndeks‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (yeni pencere açar)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (yeni pencere açar)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Kaynak‎: Am J Obstet Gynecol.

İndeks‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (yeni pencere açar)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (yeni pencere açar)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Kaynak‎: S Afr Med J 2016;106(4):399-402.

İndeks‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (yeni pencere açar)

Prophylactic use of ergot alkaloids in the third stage of labour. (yeni pencere açar)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Kaynak‎: Cochrane Database Syst Rev 2007;(2):CD005456.

İndeks‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (yeni pencere açar)

Treatment for primary postpartum haemorrhage. (yeni pencere açar)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Kaynak‎: Cochrane Database Syst Rev 2014;(2):CD003249.

İndeks‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (yeni pencere açar)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (yeni pencere açar)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Kaynak‎: Obstet Gynecol 2001;98(3):386-90.

İndeks‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (yeni pencere açar)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (yeni pencere açar)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Kaynak‎: Int J Gynaecol Obstet 2014;127(2):175-9.

İndeks‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (yeni pencere açar)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (yeni pencere açar)

Ragab A, Barakat R, Alsammani MA.

Kaynak‎: Int J Gynaecol Obstet 2016;132(1):82-4.

İndeks‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (yeni pencere açar)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (yeni pencere açar)

Roach MK, Abramovici A, Tita AT.

Kaynak‎: Am J Perinatol 2013;30(7):523-8.

İndeks‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (yeni pencere açar)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (yeni pencere açar)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Kaynak‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

İndeks‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (yeni pencere açar)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (yeni pencere açar)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Kaynak‎: Lancet Glob Health. 2023 11(2):e287-e295.

İndeks‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (yeni pencere açar)

Intravenous sulprostone infusion in the treatment of retained placenta. (yeni pencere açar)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Kaynak‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

İndeks‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (yeni pencere açar)

Carbetocin for preventing postpartum haemorrhage. (yeni pencere açar)

Su LL, Chong YS, Samuel M.

Kaynak‎: Cochrane Database Syst Rev 2012;(4):CD005457.

İndeks‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (yeni pencere açar)

Prostaglandins for preventing postpartum haemorrhage. (yeni pencere açar)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Kaynak‎: Cochrane Database Syst Rev 2012;(8):CD000494.

İndeks‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (yeni pencere açar)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (yeni pencere açar)

Westhoff G, Cotter AM, Tolosa JE.

Kaynak‎: Cochrane Database Syst Rev 2013;(10):CD001808.

İndeks‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (yeni pencere açar)